Profile data is unavailable for this security.
About the company
Otsuka Holdings Co., Ltd. is a Japan-based company mainly engaged in the medical and nutraceuticals related business and other businesses. The Company operates through four business segments. The Medical-related segment is engaged in the sale of ethical drugs, and the research development and export of therapeutic drugs. The Nutraceuticals-related segment is engaged in the manufacture, purchase and sale of nutraceuticals-related products, such as functional food and dietary supplements. The Consumer-related segment is engaged in the manufacture and sale of consumer products and mineral water. The Others segment is engaged in the manufacture and sale of chemical products, the manufacture, sale and import of measuring equipment, and the manufacture of synthetic resin molding products.
- Revenue in JPY (TTM)1.43tn
- Net income in JPY143.40bn
- Incorporated2008
- Employees32.99k
- LocationOtsuka Holdings Co Ltd2-9, Kandatsukasa-machiCHIYODA-KU 101-0048JapanJPN
- Phone+81 367171410
- Fax+81 367171409
- Websitehttps://www.otsuka.com/jp/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| TAISHO PHARMACEUTICAL HOLDINGS Co Ltd | 302.22bn | 16.85bn | 600.23bn | 9.35k | 33.44 | 0.7868 | 14.75 | 1.99 | 210.79 | 210.79 | 3,782.35 | 8,959.97 | 0.3545 | 2.47 | 4.85 | 32,309,070.00 | 2.23 | 4.01 | 2.48 | 4.44 | 61.51 | 63.48 | 6.30 | 11.37 | 5.28 | -- | 0.00 | 28.94 | 10.31 | -0.1361 | -57.75 | -3.50 | 9.61 | 0.00 |
| Kobayashi Pharmaceutical Co Ltd | 155.31bn | 19.15bn | 1.00tn | 3.44k | 49.79 | 5.30 | 42.07 | 6.45 | 245.03 | 245.03 | 1,987.06 | 2,301.24 | 0.6905 | 3.31 | 3.28 | 45,214,560.00 | 8.51 | -- | 10.60 | -- | 57.87 | -- | 12.33 | -- | 3.53 | -- | 0.0038 | -- | 0.3421 | -- | 6.19 | -- | -- | -- |
| Shionogi & Co Ltd | 318.19bn | 117.19bn | 1.77tn | 5.22k | 14.91 | 2.11 | 13.59 | 5.57 | 381.41 | 381.41 | 1,033.15 | 2,696.16 | 0.3723 | 1.29 | 5.16 | 60,932,210.00 | 13.71 | 14.01 | 14.99 | 15.83 | 83.68 | 80.01 | 36.82 | 30.57 | 7.26 | -- | 0.0133 | 25.13 | -9.40 | 4.00 | -10.93 | 22.63 | -2.53 | 14.65 |
| Otsuka Holdings Co Ltd | 1.43tn | 143.40bn | 2.49tn | 32.99k | 17.11 | 1.32 | 10.98 | 1.73 | 260.52 | 260.52 | 2,645.11 | 3,365.66 | 0.5522 | 2.64 | 4.05 | 43,478,420.00 | 5.65 | 4.23 | 6.83 | 5.20 | 68.75 | 66.81 | 10.24 | 7.99 | 2.01 | -- | 0.1129 | 52.45 | 8.07 | -- | 54.14 | -- | -- | -- |
| Astellas Pharma Inc | 1.27tn | 139.72bn | 3.09tn | 15.88k | 22.18 | 2.32 | 14.66 | 2.44 | 74.86 | 74.86 | 679.39 | 715.83 | 0.6004 | 1.69 | 3.79 | 79,698,670.00 | 6.63 | 10.56 | 8.97 | 14.05 | 79.66 | 76.95 | 11.04 | 15.09 | 1.08 | -- | 0.2353 | 36.12 | -0.4214 | 0.8448 | -12.08 | 7.54 | -0.8211 | 5.92 |
| Takeda Pharmaceutical Co Ltd | 3.22tn | 56.05bn | 5.67tn | 47.50k | 100.95 | 1.21 | 9.81 | 1.76 | 35.66 | 35.66 | 2,055.36 | 2,982.30 | 0.2547 | 1.28 | 4.20 | 67,834,590.00 | 0.4431 | 1.63 | 0.5108 | 2.07 | 68.48 | 68.86 | 1.74 | 5.28 | 1.08 | 1.57 | 0.5126 | 164.44 | 56.93 | 13.11 | -67.28 | -- | 14.90 | 0.00 |
| Chugai Pharmaceutical Co Ltd | 753.85bn | 202.59bn | 9.67tn | 7.39k | 46.79 | 10.24 | -- | 12.83 | 123.15 | 123.15 | 458.27 | 562.88 | 0.6976 | 1.52 | 3.57 | 101,954,700.00 | 18.75 | 10.34 | 22.53 | 12.25 | 64.81 | 54.45 | 26.87 | 15.80 | 3.05 | 529.71 | 0.00 | 49.76 | 18.35 | 8.27 | 70.36 | 25.32 | 26.13 | 23.87 |
Data as of Jan 21 2021. Currency figures normalised to Otsuka Holdings Co Ltd's reporting currency: Japanese Yen JPY
16.38%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Nomura Asset Management Co., Ltd.as of 30 Aug 2019 | 24.76m | 4.44% |
| The Vanguard Group, Inc.as of 31 Dec 2020 | 11.46m | 2.05% |
| Daiwa Asset Management Co. Ltd.as of 30 Dec 2020 | 11.42m | 2.05% |
| Nikko Asset Management Co., Ltd.as of 30 Dec 2020 | 11.28m | 2.02% |
| T. Rowe Price International Ltd.as of 30 Sep 2020 | 8.03m | 1.44% |
| Norges Bank Investment Managementas of 31 Dec 2019 | 6.38m | 1.14% |
| BlackRock Fund Advisorsas of 07 Jan 2021 | 6.02m | 1.08% |
| Mitsubishi UFJ Kokusai Asset Management Co., Ltd.as of 12 Oct 2020 | 5.55m | 1.00% |
| T. Rowe Price Associates, Inc. (Investment Management)as of 30 Nov 2020 | 3.56m | 0.64% |
| Geode Capital Management LLCas of 14 Jan 2021 | 2.91m | 0.52% |
More ▼
Data from 31 Dec 2019 - 30 Nov 2020Source: FactSet Research Systems Inc.
